We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+6.68%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$17.7B
AUM Growth
+$1.64B
Cap. Flow
+$829M
Cap. Flow %
4.68%
Top 10 Hldgs %
32.88%
Holding
1,375
New
60
Increased
737
Reduced
285
Closed
62

Top Buys

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$115M
2
ESS icon
Essex Property Trust
ESS
+$110M
3
AAPL icon
Apple
AAPL
+$103M
4
TSLA icon
Tesla
TSLA
+$101M
5
MSFT icon
Microsoft
MSFT
+$97.5M

Top Sells

Rank Stock Value
1
MAA icon
Mid-America Apartment Communities
MAA
+$122M
2
SUI icon
Sun Communities
SUI
+$107M
3
SPG icon
Simon Property Group
SPG
+$104M
4
WPC icon
W.P. Carey
WPC
+$76.5M
5
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
+$70.5M

Sector Composition

Rank Sector Weight
1 Real Estate 45.88%
2 Technology 16.72%
3 Consumer Discretionary 5.58%
4 Communication Services 5.5%
5 Financials 5.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CSTL icon
1251
Castle Biosciences
CSTL
$742M
$2K ﹤0.01%
86
– –
CVAC
1252
DELISTED
CureVac
CVAC
$2K ﹤0.01%
697
– –
EOLS icon
1253
Evolus
EOLS
$397M
$2K ﹤0.01%
162
– –
LKFT
1254
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.82B
$2K ﹤0.01%
51
– –
ITOS
1255
DELISTED
iTeos Therapeutics
ITOS
$2K ﹤0.01%
121
– –
KALV
1256
DELISTED
KalVista Pharmaceuticals
KALV
$2K ﹤0.01%
+154
New +$2.05K
LYEL icon
1257
Lyell Immunopharma
LYEL
$318M
$2K ﹤0.01%
46
– –
MLYS icon
1258
Mineralys Therapeutics
MLYS
$2.32B
$2K ﹤0.01%
+152
New +$1.88K
NRIX icon
1259
Nurix Therapeutics
NRIX
$2.45B
$2K ﹤0.01%
152
– –
PHAT icon
1260
Phathom Pharmaceuticals
PHAT
$928M
$2K ﹤0.01%
167
– –
REPL icon
1261
Replimune Group
REPL
$454M
$2K ﹤0.01%
200
– –
SIGA icon
1262
SIGA Technologies
SIGA
$240M
$2K ﹤0.01%
270
– –
TBPH icon
1263
Theravance Biopharma
TBPH
$873M
$2K ﹤0.01%
215
– –
TRML
1264
DELISTED
Tourmaline Bio
TRML
$2K ﹤0.01%
+95
New +$3.35K
TSHA icon
1265
Taysha Gene Therapies
TSHA
$1.61B
$2K ﹤0.01%
+691
New +$1.44K
TVTX icon
1266
Travere Therapeutics
TVTX
$5.17B
$2K ﹤0.01%
258
– –
VYGR icon
1267
Voyager Therapeutics
VYGR
$181M
$2K ﹤0.01%
+201
New +$1.7K
WVE icon
1268
Wave Life Sciences
WVE
$1.12B
$2K ﹤0.01%
349
– –
RVNC
1269
DELISTED
Revance Therapeutics, Inc.
RVNC
$2K ﹤0.01%
331
– –
PETQ
1270
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$2K ﹤0.01%
99
– –
MRNS
1271
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$2K ﹤0.01%
202
+144
+248% +$1.4K
ABUS icon
1272
Arbutus Biopharma
ABUS
$847M
$1K ﹤0.01%
395
– –
AMLX icon
1273
Amylyx Pharmaceuticals
AMLX
$2.19B
$1K ﹤0.01%
266
– –
AMRN
1274
Amarin Corp
AMRN
$297M
$1K ﹤0.01%
67
– –
ATAI icon
1275
AtaiBeckley Inc
ATAI
$2.66B
$1K ﹤0.01%
468
– –
49 50
51
52 53

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Daiwa Securities Group's Q1 2024 Portfolio in Review

As of Q1 2024, Daiwa Securities Group held 1,375 positions worth $17.7B, up 10% from $16.1B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Daiwa Securities Group deployed $829M of net new capital in Q1 2024, opening 60 new positions and adding to 737 existing holdings. Its largest new stake was American Healthcare REIT: 241,461 shares worth $3.56M.

By sector, the portfolio is most concentrated in Real Estate at 46% of assets, down from 52% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Mid-America Apartment Communities, an estimated $122M trimmed.

  • Daiwa Securities Group's largest Q1 2024 buy was American Healthcare REIT: 241,461 shares worth $3.56M.
  • Daiwa Securities Group added most to Equinix in Q1 2024, an estimated $115M increase.
  • Daiwa Securities Group's biggest Q1 2024 reduction was Mid-America Apartment Communities, cutting an estimated $122M.
  • Daiwa Securities Group fully exited SPIRIT REALTY CAPITAL, INC. in Q1 2024, selling an estimated $70.5M.
  • Daiwa Securities Group's ten largest holdings make up 33% of its $17.7B portfolio in Q1 2024.
  • Daiwa Securities Group opened 60 new positions and closed 62 in Q1 2024.
  • Daiwa Securities Group's portfolio value rose 10% quarter-over-quarter to $17.7B.

Based on Daiwa Securities Group's 13F filing for Q1 2024, filed 2 May 2024.